Media

December 17, 2024

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

December 10, 2024

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

December 9, 2024

Virax Biolabs: Interview With COO Nigel McCracken About The Diagnostics And Detection Company

by Amit Chowdhry of Pulse 2.0

November 21, 2024

A Diagnosis in Demand – The Urgent Need for Post-Acute Infection Syndrome (PAIS) Testing by Dr. Elihu Aranday-Cortes

November 15, 2024

Discovering Solutions for Long COVID: A T Cell Immunology Breakthrough (feat. Dr. Nigel McCracken)

by Tori Whitacre Martonicz of Infection Control Today

October 24, 2024

Detecting T Cell Dysfunction in Post-Acute Infection Syndromes (feat. Dr. Nigel McCracken)

by Sophia Abene of Contagion Live

October 23, 2024

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

September 16, 2024

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits with Cosmos Health Inc.

September 9, 2024

Virax Biolabs Presents at H.C. Wainwright’s 26th Annual Global Investment Conference

August 30, 2024

Virax Biolabs to Participate in the 7th European Congress of Immunology 2024

Virax Biolabs are excited to announce our attendance at the 7th European Congress of Immunology (ECI), taking place in Dublin. The Congress runs from 1-4th September, and you can visit

August 28, 2024

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

August 1, 2024

Dr. Ailsa Snaith Joins the Virax Biolabs Team

We’re excited to welcome Dr. Ailsa Snaith to the Virax Biolabs team today – she will be the newest member of our Advisory Board. A scientist and clinician with a